FDA Warns CorePharma Over Manufacturing Issues

Law360, New York (August 11, 2010, 4:31 PM EDT) -- The U.S. Food and Drug Administration has warned pharmaceutical company CorePharma LLC about alleged problems with its manufacturing processes, including an incident where the company manufactured drugs in a room with only a curtain separating it from a working construction site.

CorePharma's quality control unit is either not doing its job, or has not been given the authority to, the FDA said in a letter made public Tuesday. The agency cited several alleged violations of good manufacturing practice at the company's Middlesex, N.J., drug plant....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.